Elite Pharmaceuticals Inc (ELTP)

[rollin2nyte]

We shouldn't rule out the possibility that NH is posturing to increase a buyout offer. Whether or not uplisting to the NASDAQ makes sense does not affect it's impact to future negotiations. The threat of organic growth, including uplisting, will benefit ELTP shareholders despite how realistic that scenario is. It's obvious that Epic does not have the horsepower to extract as much profits as needed within the 3-5 year window. If you were to partner with Epic you'd think a product with a smaller revenue base would be the preferred kickoff. Then incur incremental profits off that to wiggle into a partnership with a large pharma. By introducing ELI-200 as the first offering seems a bit off to me with regards to maximizing profits. Something interesting is going on behind the scenes.